Literature DB >> 10565516

Screening for glaucoma with frequency-doubling technology and Damato campimetry.

N Yamada1, P P Chen, R P Mills, M M Leen, M F Lieberman, R L Stamper, D C Stanford.   

Abstract

OBJECTIVE: To assess frequency-doubling technology (FDT) perimetry (Humphrey Systems, San Leandro, Calif) and Damato campimetry (Precision Vision, Villa Park, Ill) for detecting glaucoma in a public glaucoma screening.
METHODS: A 2-day public glaucoma screening was held at 2 different institutions. Each subject underwent 2 visual field screening tests (Damato campimetry and FDT perimetry in screening mode), an ophthalmologic examination, and Humphrey perimetry (24-2 FASTPAC) for each eye. Eyes were divided into 4 categories: normal, ocular hypertensive, glaucoma suspect, and definite glaucoma. The sensitivity and specificity of FDT perimetry and Damato campimetry for detecting glaucoma were estimated with receiver operating characteristic curves.
RESULTS: Among 240 subjects who underwent FDT, the number identified as normal, ocular hypertensive, glaucoma suspect, and definite glaucoma was 151, 28, 35, and 26, respectively; among 175 subjects who underwent Damato campimetry, the numbers for the same groups were 118, 19, 19, and 19, respectively. The areas under the receiver operating characteristic curve for FDT perimetry and Damato campimetry were 0.925 and 0.883, respectively. The optimal sensitivity and specificity for FDT perimetry were 92% and 93%, while those for Damato campimetry were 53% and 90%, respectively. The average test time was 1 minute and 3 minutes per eye for FDT perimetry and Damato campimetry, respectively.
CONCLUSION: Frequency-doubling technology perimetry was superior to Damato campimetry in this screening for glaucoma.

Entities:  

Mesh:

Year:  1999        PMID: 10565516     DOI: 10.1001/archopht.117.11.1479

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  Clinical comparison of frequency doubling technology perimetry and Humphrey perimetry.

Authors:  R Casson; B James; A Rubinstein; H Ali
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  Characteristics of the normative database for the Humphrey matrix perimeter.

Authors:  Andrew John Anderson; Chris A Johnson; Murray Fingeret; John L Keltner; Paul G D Spry; Michael Wall; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

3.  Performance of the 24-2-5 frequency doubling technology screening test: a prospective case study.

Authors:  P G D Spry; H M Hussin; J M Sparrow
Journal:  Br J Ophthalmol       Date:  2007-03-27       Impact factor: 4.638

4.  Population and high-risk group screening for glaucoma: the Los Angeles Latino Eye Study.

Authors:  Brian A Francis; Rohit Varma; Cheryl Vigen; Mei-Ying Lai; Jonathan Winarko; Betsy Nguyen; Stanley Azen
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-05       Impact factor: 4.799

5.  Meta-analysis of the diagnostic efficiency of frequency-doubling technology for primary glaucoma.

Authors:  Ting Liu; Xiangge He
Journal:  Front Med China       Date:  2007-02

6.  Glaucoma detection with damato multifixation campimetry online.

Authors:  A S Olsen; M Alberti; L Serup; M la Cour; B Damato; M Kolko
Journal:  Eye (Lond)       Date:  2016-03-18       Impact factor: 3.775

7.  Frequency doubling perimetry and the detection of eye disease in the community.

Authors:  G A Cioffi; S Mansberger; P Spry; C Johnson; E M Van Buskirk
Journal:  Trans Am Ophthalmol Soc       Date:  2000

8.  Clinical evaluation of frequency doubling technology perimetry using the Humphrey Matrix 24-2 threshold strategy.

Authors:  P G D Spry; H M Hussin; J M Sparrow
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

9.  Multifixation campimetry on line: a perimeter for the detection of visual field loss using the internet.

Authors:  B Damato; C Groenewald
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

10.  The papilla as screening parameter for early diagnosis of glaucoma.

Authors:  Georg Michelson; Simone Wärntges; Joachim Hornegger; Berthold Lausen
Journal:  Dtsch Arztebl Int       Date:  2008-08-25       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.